GlobeNewswire Inc.··NaEvaxion to Report 2025 Results, Showcase AI-Immunology Platform Progress
Danish biotech $EVAX will announce full-year 2025 financial results and business update March 5, detailing AI-Immunology platform development across oncology, infectious disease, and autoimmune applications.
EVAXfinancial resultsclinical-stage